H3Q.F TOBII DYNAVOX AB

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
6.63 EUR
Close of Nov 12, 2026
5.10 9.55
Market cap
EUR 703M
P/E
27.6x
P/B
9.19x
ROE
32.2%
Dividend yield
0.69%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is H3Q.F undervalued?

Graham number

The Graham number of TOBII DYNAVOX AB cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TOBII DYNAVOX AB fundamental analysis

No fundamental analysis for TOBII DYNAVOX AB yet.

TOBII DYNAVOX AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About TOBII DYNAVOX AB

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its communication solutions include language, software, hardware, funding, support, and tr…

Full company profile